René van der Griend

Phase III Study of the Value of Thalidomide Added to Melphalan Plus Prednisone in Elderly Patients With Newly Diagnosed Multiple Myeloma: The HOVON 49 Study

Pierre W. Wijermans, M. Ronald Schaafsma, Fabian Termorshuizen et al. · Journal of Clinical Oncology · 2010 · 262 citations

Medicine, Oncology, Pharmacotherapy +17

Is extensive screening for cancer in idiopathic venous thromboembolism warranted?

Frederiek F van Doormaal, Wim Terpstra, René van der Griend et al. · Journal of Thrombosis and Haemostasis · 2010 · 141 citations · Full text

Medicine, Hematology, Oncology +12

Out of hospital treatment of acute pulmonary embolism in patients with a low NT‐proBNP level

Mariëtte J Agterof, Roger E. G. Schutgens, Repke J. Snijder et al. · Journal of Thrombosis and Haemostasis · 2010 · 137 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +8

Homocysteine in Inflammatory Bowel Disease: A Risk Factor for Thromboembolic Complications?

Bas Oldenburg, Rob Fijnheer, René van der Griend et al. · The American Journal of Gastroenterology · 2000 · 110 citations

Public Health, Hematology, Hemostasis +10

Radiation therapy for aggressive fibromatosis. The Experience at the University of Florida.

W. Mark McCollough, James T. Parsons, René van der Griend et al. · Journal of Bone and Joint Surgery · 1991 · 96 citations

Medicine, Oncology, Radiation Oncology +8